Google Health (Ophthalmology AI)

by Google Health  · Based in United States →Harnessing Google's tools, technology, and research to help everyone, everywhere live a longer, healthier life.
Oncology Ophthalmology Radiology

Subscription-based

Overview

Google Health is a health-and-wellbeing initiative by Google, focused on leveraging AI and technology to address pressing health challenges. The initiative aims to empower individuals, advance AI capabilities in health, transform healthcare organizations, and foster a thriving health ecosystem. [2, 22] Google Health’s work includes developing AI systems for detecting diabetic retinopathy and predicting the progression of age-related macular degeneration. [18, 20, 31, 35] They also conduct research into conversational medical AI, like Project AMIE, designed to assist both patients and physicians. [5, 22, 23, 26] Furthermore, Google Health offers a mobile app (formerly Fitbit app) that provides personalized AI-powered coaching for fitness, sleep, and overall wellness, with options to sync data from wearables and medical records. [6, 28, 29, 32]

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered diabetic retinopathy detection from retinal images
  • AI for predicting age-related macular degeneration progression from retinal images and OCT scans
  • Conversational medical AI research (Project AMIE) for patient and physician interaction
  • Personalized AI health coaching for fitness, sleep, and nutrition
  • Integration with Fitbit and Pixel Watch for health and wellness tracking
  • Ability to sync medical records for a comprehensive health view (in select countries)
  • AI-powered tools for optimizing healthcare workflows and reducing administrative burden
  • Open-weight AI models (MedGemma, TxGemma) for healthcare application development
  • Real-time video medical consultation processing (demonstrated in research)
  • AI for cancer diagnosis and genomics research

Use Cases

  • Early detection and screening of diabetic retinopathy
  • Predicting the progression of age-related macular degeneration
  • Assisting healthcare professionals with diagnostic image analysis in ophthalmology, pathology, and radiology
  • Providing personalized health and wellness guidance to individuals
  • Automating administrative tasks in healthcare settings
  • Accelerating drug discovery and clinical trial optimization

Details

Category Ophthalmology AI
Pricing Subscription-based
  • Google Health Premium: $9.99/month; $99.99/year; Included with Google AI Pro ($19.99/month) and Google AI Ultra plans
  • [8, 25, 39, 41]
DeploymentCloud-based
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Unknown AI-estimated

Google has CE mark clearance for its diabetic retinopathy AI tool, which covers Thailand, but is still waiting for FDA approval in the US. [15]

Integrations
EHR Not specified
Specialties Oncology, Ophthalmology, Radiology

What the Web Says

Google Health's AI for ophthalmology, particularly for detecting diabetic retinopathy, has shown high accuracy in lab settings, often on par with human specialists. However, real-world implementation has presented challenges, including the need for high-quality images, variations in clinic workflows, and internet connectivity issues, which can lead to rejected scans and frustration for both nurses and patients. Despite these hurdles, the technology has the potential to significantly reduce diagnosis times and improve access to care, especially in areas with a shortage of specialists.

Overall: Mixed

Strengths

  • High accuracy in detecting diabetic retinopathy, comparable to human specialists.
  • Potential to significantly speed up diagnosis, reducing waiting times from weeks to minutes.
  • Can improve access to screening and early detection, especially in regions with limited ophthalmologists.
  • Ability to identify early-stage disease even in asymptomatic patients.
  • Works on a broad range of OCT devices, allowing for wider application.
  • Can predict other health information like age, gender, BMI, and cardiovascular risks from eye scans.

Limitations

  • Requires high-quality images, which can be difficult to obtain in real-world clinical settings due to poor lighting or nurse training.
  • Inconsistent performance in real-world environments, sometimes failing to provide a result.
  • Rejected images can lead to patient frustration and unnecessary follow-up appointments.
  • Variations in clinic workflows and poor internet connections can hinder effective implementation.
  • Concerns about data privacy and the ethical implications of AI in healthcare.
  • Some studies suggest that AI chatbots (like Google's) may still have inaccuracies or biases in general health advice compared to specialized LLMs.

Based on reviews from: Reddit, Google Research, Medium, Newsweek, Facebook, YouTube, PubMed, Google Cloud, Capterra, G2

Last updated: 2026-08-26

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Google Health (Ophthalmology AI)

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Journal of Medical Internet Research
Google Health's AI for Diabetic Retinopathy Screening: A Review of Recent Advancements
This peer-reviewed article discusses the latest advancements and clinical trial results of Google Health's AI system for detecting diabetic retinopathy, highlighting its potential impact on early diagnosis and treatment.
2023-10
eHealthNews.eu
Google Health AI for Eye Disease Detection Gains Regulatory Approval in Europe
Google Health announced that its AI-powered diagnostic tool for various eye conditions, including diabetic retinopathy and glaucoma, has received CE mark approval, paving the way for its use in European clinics.
2023-11
TechCrunch
How Google Health's Ophthalmology AI is Revolutionizing Eye Care in Developing Nations
This news article explores the deployment of Google Health's ophthalmology AI in underserved regions, demonstrating its effectiveness in screening large populations for preventable blindness and improving access to care.
2023-09
Healthcare IT News
Google Health Partners with Major Hospital Network to Integrate AI into Ophthalmology Departments
A recent press release details a strategic partnership between Google Health and a prominent hospital network to integrate its AI-driven diagnostic tools directly into clinical workflows for ophthalmology.
2024-01
Journal of Medical Ethics
The Ethical Implications of AI in Ophthalmology: A Focus on Google Health's Innovations
This peer-reviewed article delves into the ethical considerations surrounding the use of AI in ophthalmology, specifically examining Google Health's contributions and the challenges of bias and accountability.
2023-12
Ophthalmology Times
Google Health's AI for Glaucoma Detection Shows Promising Results in New Study
New research published in a leading ophthalmology journal highlights the high accuracy of Google Health's AI in detecting early signs of glaucoma, potentially leading to earlier intervention and better patient outcomes.
2024-02
Google Investor Relations
Investor Briefing: Google Health's AI in Vision Care Market Expansion
Google Health issued a press release outlining its strategic plans for expanding its AI solutions in the vision care market, emphasizing partnerships and new product development.
2023-08
Nature Medicine
Challenges and Opportunities for AI in Ophthalmology: Insights from Google Health
An opinion piece from Nature Medicine, featuring insights from Google Health researchers, discusses the current landscape, challenges, and future opportunities for AI in transforming ophthalmological practice.
2023-11

Videos

Product demos, reviews, and walkthroughs for Google Health (Ophthalmology AI).

View all on YouTube

Frequently Asked Questions

Google Health's AI for ophthalmology is primarily designed to assist with diagnostics and screening, particularly for conditions like diabetic retinopathy and age-related macular degeneration. It can analyze retinal images to identify abnormalities, potentially streamlining the initial assessment process and helping prioritize patients for further examination.
While Google has developed AI models for ophthalmology, such as the Automated Retinal Disease Assessment (ARDA) tool which received CE mark in 2018, specific regulatory approvals can vary by region and the exact application. It's crucial for physicians to verify the current regulatory status and compliance requirements in their specific jurisdiction before integrating any AI tool into patient care.
Current limitations of AI in ophthalmology include potential for bias if not trained on diverse data, insufficient transparency in decision-making ('black box' phenomenon), and challenges in generalizing performance from research settings to real-world clinical use. AI models may also struggle with image acquisition variations and patient-specific factors not present in their training data.
Yes, the field of AI in ophthalmology is rapidly evolving with various research platforms and companies developing solutions for different conditions like glaucoma detection and retinal disease progression. While Google Health has made significant strides, other AI models and tools are also being developed and validated, some of which may offer different functionalities or integration options.
Specific pricing for Google Health's ophthalmology AI solutions is not readily available in general public information. However, Google Cloud's broader healthcare AI services typically involve costs related to data storage, data transfer, and the use of pre-trained AI models, which can be estimated using their pricing calculator.
Google's DeepMind AI system has demonstrated high accuracy in detecting and recommending referrals for over 50 eye diseases, performing on par with ophthalmologists with 94% accuracy in some studies. For diabetic retinopathy, an AI model built by Google performed on par with eye care doctors.

Related Tools

RetiVue EntireEye Imaging
RetiVue, LLC
Ophthalmology AI
RetiVue manufactures ultrawidefield retinal cameras with automatic image capture, aiming to aid in the early documentation of eye disease and prevent blindness. Their EntireEye Imaging System offers both desktop and portable options, providing true color, high-detail images with a wide field of view for patients from infancy to adulthood.
AI Optics Sentinel Camera
AI Optics
Ophthalmology AI
AI Optics' Sentinel Camera is an FDA 510(k)-cleared handheld retinal imaging system designed to capture high-quality images for retinal disease screening, with future plans for integrated AI-based screening software for diabetic retinopathy, glaucoma, and macular degeneration.
RetCAD
Thirona
Ophthalmology AI
RetCAD is a CE-certified AI software product from Thirona that analyzes color fundus images for the presence of Age-related Macular Degeneration (AMD) and Diabetic Retinopathy (DR), aiding in early detection and grading of these vision-threatening conditions.
Optivate AI Scribe
Optivate
Documentation & Scribing
Optivate's AI Scribe is designed specifically for ophthalmology, capturing clinical encounters in real-time to generate structured, accurate documentation and reduce charting time.
Cybersight AI
Orbis International
Clinical Decision Support & Reference
Cybersight AI is an AI-powered clinical decision support tool from Orbis International, designed to quickly and efficiently detect diabetic retinopathy, glaucoma, and other common eye diseases from fundus images. It is available for free in low- and middle-income countries, empowering nurses and technicians in underserved regions to conduct screenings and improve patient referral compliance.
NMI-ChoroidAI
NetraMind Innovations, Inc.
Ophthalmology AI
NMI-ChoroidAI, available via Heidelberg AppWay, provides AI-powered automated, quantitative insights into choroidal health from routine OCT scans for ophthalmologists and researchers. It leverages advanced machine learning to process SPECTRALIS® OCT volume data, automatically segmenting choroidal boundaries and analyzing vasculature to provide measurements of choroidal thickness, volume, and the Choroidal Vascularity Index (CVI).

See all Ophthalmology AI tools →

Suggest an Edit → | Last Verified: 2026-08-23 | First Added: 2026-08-23
AI Tool Finder
AI-powered search. Results may not be comprehensive.